Market Overview:
The global artificial pancreas systems market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing prevalence of diabetes, technological advancements in artificial pancreas systems, and rising awareness about these systems. The global artificial pancreas systems market can be segmented on the basis of type into control to range (CTR) system and control to target (CTT) system. The CTR system is further sub-segmented into threshold suspended device and sensor augmented pump therapy. The CTT system is further sub-segmented into closed loop insulin delivery and dual hormone pump therapy. On the basis of application, the global artificial pancreas systems market can be divided into diabetes type 1 and diabetes type 2. Diabetes type 1 is further classified as juvenile onset diabetes mellitus (JODM), insulin dependent diabetes mellitus (IDDM), early onset adult IDDM, late onset adult IDDM, latent autoimmune diabetic ketoacidosis (LADA), maturity onset diabetes of youth (MODY). Diabetes type 2 is classified as non-insulin dependent diabetes mellitus(NIDDM), gestational DM, secondary DM, steroid induced DM etcetera . Geographically, the global artificial pancreas systems market can be segmented into North America , Latin America , Europe , Asia Pacific and Middle East & Africa .
Product Definition:
An artificial pancreas system (APS) is a device that mimics the functions of the pancreas in people with diabetes. The APS consists of two parts: a continuous glucose monitor (CGM) and an insulin pump. The CGM monitors blood sugar levels and sends information to the insulin pump, which then calculates how much insulin to deliver to keep blood sugar levels within target range. An APS is important because it can help people with diabetes better manage their blood sugar levels, which can lead to improved health outcomes.
Control to Range (CTR) System:
Control to range (CTR) system is a technology that helps in maintaining the blood glucose level in an individual. It works by measuring the amount of insulin delivered by an artificial pancreas. The Control to range system uses a sensor and some algorithms which are connected to an insulin pump or a manual infusion set. This device has been approved for use with BGM systems, but it can also be used with other devices such as home dialysis equipment and hospital machines.
Control to Target (CTT) System:
Control to Target (CTT) is a system used in artificial pancreas systems. It helps to adjust the amount of insulin delivered by an implanted device according to the blood sugar level. The CTT system consists of two components, namely, a control unit and a sensor unit which are both connected by wireless communication.
The major functions performed by this system include data processing and analysis, as well as controlling the delivery of insulin according to glucose levels measured from sensor readings.
Application Insights:
Diabetes type 1 held the largest share of 26.1% in 2017 owing to the increasing prevalence of diabetes and its associated complications. With an estimated incidence of 6-7 million people across the world, diabetic retinopathy is one of the major concerns for patients suffering from diabetes type 1. Thus, artificial pancreas systems are expected to witness significant growth over next eight years due to rising adoption and awareness regarding this technology among patients with diabetes type 1.
The other application segment includes Type 2 Diabetes mellitus which is also known as adult-onset or non-insulin dependent diabetes mellitus (NIDDM). This condition is a growing concern because it often goes undiagnosed due to lack of symptoms until severe enough pathology has developed leading to blindness, kidney failure etcetera.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of diabetes type 1 and 2, increasing healthcare expenditure, technological advancements, and government initiatives. In addition, an increase in research funding for pancreas devices is expected to fuel the growth during the forecast period. Europe accounted for a significant share of revenue due to high demand from patients suffering from diabetes type 1 & 2 as well as other chronic diseases such as kidney failure or acid reflux disease (GERD). The presence of major players such as Becton; Dickinson and Company; Medtronic plc.; Novo Nordisk A/S; Roche Holding Ltd.; Sanofi SA & Co., Genzyme Corporation has also fueled growth.
The Asia Pacific Diabetes Prevention Initiative was launched by WHO.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is expected to drive the demand for artificial pancreas systems in the coming years.
- Technological advancements: The development of novel technologies has led to the introduction of advanced artificial pancreas systems that are more efficient and accurate than earlier versions. This is likely to boost the growth of this market in the coming years.
- Growing awareness about diabetes and its complications: There is a growing awareness among people about diabetes and its complications, which is likely to increase demand for artificial pancreas systems in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Artificial Pancreas Systems Market Research Report
By Type
Control to Range (CTR) System, Control to Target (CTT) System, Threshold Suspended Device
By Application
Diabetes Type 1, Diabetes Type 2
By Companies
Medtronic, JDRF, Tandem Diabetes Care, Pancreum, TypeZero Technologies, Beta Bionics, Johnson & Johnson, Insulet Corp, Bigfoot Biomedical, Dexcom, Medtronic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
228
Number of Tables & Figures
160
Customization Available
Yes, the report can be customized as per your need.
Global Artificial Pancreas Systems Market Report Segments:
The global Artificial Pancreas Systems market is segmented on the basis of:
Types
Control to Range (CTR) System, Control to Target (CTT) System, Threshold Suspended Device
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetes Type 1, Diabetes Type 2
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- JDRF
- Tandem Diabetes Care
- Pancreum
- TypeZero Technologies
- Beta Bionics
- Johnson & Johnson
- Insulet Corp
- Bigfoot Biomedical
- Dexcom
- Medtronic
Highlights of The Artificial Pancreas Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Control to Range (CTR) System
- Control to Target (CTT) System
- Threshold Suspended Device
- By Application:
- Diabetes Type 1
- Diabetes Type 2
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Artificial Pancreas Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Artificial pancreas systems are medical devices that help people with diabetes manage their blood sugar levels. The devices work by detecting when a person has low blood sugar and automatically releasing insulin to bring the person's blood sugar back up to a safe level.
Some of the key players operating in the artificial pancreas systems market are Medtronic, JDRF, Tandem Diabetes Care, Pancreum, TypeZero Technologies, Beta Bionics, Johnson & Johnson, Insulet Corp, Bigfoot Biomedical, Dexcom, Medtronic.
The artificial pancreas systems market is expected to register a CAGR of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Artificial Pancreas Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Artificial Pancreas Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Artificial Pancreas Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Artificial Pancreas Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Artificial Pancreas Systems Market Size & Forecast, 2020-2028
4.5.1 Artificial Pancreas Systems Market Size and Y-o-Y Growth
4.5.2 Artificial Pancreas Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Control to Range (CTR) System
5.2.2 Control to Target (CTT) System
5.2.3 Threshold Suspended Device
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diabetes Type 1
6.2.2 Diabetes Type 2
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Artificial Pancreas Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Artificial Pancreas Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Control to Range (CTR) System
9.6.2 Control to Target (CTT) System
9.6.3 Threshold Suspended Device
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diabetes Type 1
9.10.2 Diabetes Type 2
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Control to Range (CTR) System
10.6.2 Control to Target (CTT) System
10.6.3 Threshold Suspended Device
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diabetes Type 1
10.10.2 Diabetes Type 2
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Control to Range (CTR) System
11.6.2 Control to Target (CTT) System
11.6.3 Threshold Suspended Device
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diabetes Type 1
11.10.2 Diabetes Type 2
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Control to Range (CTR) System
12.6.2 Control to Target (CTT) System
12.6.3 Threshold Suspended Device
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diabetes Type 1
12.10.2 Diabetes Type 2
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Control to Range (CTR) System
13.6.2 Control to Target (CTT) System
13.6.3 Threshold Suspended Device
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diabetes Type 1
13.10.2 Diabetes Type 2
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Artificial Pancreas Systems Market: Competitive Dashboard
14.2 Global Artificial Pancreas Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 JDRF
14.3.3 Tandem Diabetes Care
14.3.4 Pancreum
14.3.5 TypeZero Technologies
14.3.6 Beta Bionics
14.3.7 Johnson & Johnson
14.3.8 Insulet Corp
14.3.9 Bigfoot Biomedical
14.3.10 Dexcom
14.3.11 Medtronic
